Anti-Cytomegalovirus p65 (CMV-p65) Monoklonale Antilichaam (Kloon: CMV101)

Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Recombinant CMV-p65 protein

CMV101

ELISA, ICC, IF

200 μg/mL of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA at 1.0mg/mL.

Antibody with azide - store at 2 to 8°C. Antibody is stable for 24 months. Non-hazardous.

ELISA (For coating, order Ab without BSA) ; Immunocytochemistry (Acetone or paraformaldehyde fixed) (1-2ug/ml for 30 min) ; Immunofluorescence (1-2ug/ml)

Mouse IgG1, kappa